Trade Summary

2 days ago, Burroughs Amy L., serving as CEO at Terns Pharmaceuticals, Inc. (TERN), sold 14,583 shares at $46.71 per share, for a total transaction value of $681,108.00. Following this transaction, Burroughs Amy L. now holds 297,295 shares of TERN.

This sale represents a 5.00% decrease in Burroughs Amy L.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Terns Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.